Chinese iPSC company clinical development landscape — the growing ecosystem of Chinese biotechnology companies translating iPSC technology into clinical-stage cell therapy programs across ophthalmology, cardiovascular disease, diabetes, neurological disorders, and hematological malignancies — creates the commercial frontier of Chinese iPSC market development, with the China Induced...